As cell and gene therapies continue to expand, CGT-focused CDMOs play a critical role in biomanufacturing. They provide specialized facilities, technical expertise, and regulatory support that help companies overcome complexity, reduce development timelines, maintain quality standards, and bring innovative, life-changing therapies to global healthcare markets. https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/why-cgt-focused-cdmos-are-the-future-of-biomanufacturing